How many studies have been conducted on Mitoguazone?

BiohacksAI has indexed 65 PubMed studies on Mitoguazone, including 2 randomized controlled trials (RCTs). 54% of studies involve human subjects.

What are the main research areas for Mitoguazone?

The primary research domains for Mitoguazone are 🔬 Oncology, ⏳ Longevity & Aging, 😴 Sleep. This is based on analysis of 65 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Mitoguazone

an inhibitor of animal S-adenosylmethionine decarboxylase.

65+ PubMed studies analyzed · 2 RCTs · Evidence Score: 45.2

Research Domains

Mitoguazone has been studied across 13 research domains including 🔬 Oncology, ⏳ Longevity & Aging, 😴 Sleep, 🫘 Kidney, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 60% of studies addressing this area.

Loading evidence profile...

This evidence profile for Mitoguazone is generated deterministically from 65 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.